Introduction to gPROMS for acceleration of pharma R&D & engineering

Explore how Siemens gPROMS digital twins can address key challenges in the pharmaceutical industry, including accelerating development timelines and modernizing knowledge transfer.

On-demand webinar

The pharmaceutical industry faces numerous challenges, with great urgency to accelerate development timelines, meet rapidly-changing global supply chain requirements, expand new molecule pipelines, and modernize knowledge transfer within the organization. In recent years, mechanistic modelling has gained traction in the pharmaceutical sector as a favoured approach for accelerating research, development and production. This strategy improves R&D efficiency, facilitates scale-up and technology transfer, and expedites time-to-market. In this webinar, Siemens gPROMS will be showcased as a key digitalization technology that is already delivering value across the industry.

What this webinar covers?

  • An overview of challenges in the pharmaceutical industry and how Siemens model-based digital twins can address them.
  • Case studies showing where model-based solutions and the methodologies employed provide value across the pharmaceutical process lifecycle.
  • Siemens vision on the future of digital twins in the pharmaceutical industry.

Learn how digital twins can transform pharmaceutical R&D.

pharma industry